These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30402489)

  • 21. Increased levels of soluble P-selectin in hypercholesterolemic patients.
    Davì G; Romano M; Mezzetti A; Procopio A; Iacobelli S; Antidormi T; Bucciarelli T; Alessandrini P; Cuccurullo F; Bittolo Bon G
    Circulation; 1998 Mar; 97(10):953-7. PubMed ID: 9529262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
    Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
    Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins.
    Rauch U; Osende JI; Chesebro JH; Fuster V; Vorchheimer DA; Harris K; Harris P; Sandler DA; Fallon JT; Jayaraman S; Badimon JJ
    Atherosclerosis; 2000 Nov; 153(1):181-9. PubMed ID: 11058714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients.
    Cerda A; Rodrigues AC; Alves C; Genvigir FD; Fajardo CM; Dorea EL; Gusukuma MC; Pinto GA; Hirata MH; Hirata RD
    Cardiovasc Ther; 2015 Aug; 33(4):168-76. PubMed ID: 25903419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.
    Moutzouri E; Liberopoulos EN; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
    Atherosclerosis; 2013 Nov; 231(1):8-14. PubMed ID: 24125402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.
    Pesaro AE; Serrano CV; Fernandes JL; Cavalcanti AB; Campos AH; Martins HS; Maranhão RC; de Lemos JA; Souza HP; Nicolau JC
    Int J Cardiol; 2012 Jul; 158(3):400-4. PubMed ID: 21334753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target.
    Göçmen AY; Burgucu D; Gümüşlü S
    Appl Physiol Nutr Metab; 2011 Jun; 36(3):323-30. PubMed ID: 21574786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.
    Koh KK; Cardillo C; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Circulation; 1999 Jan; 99(3):354-60. PubMed ID: 9918521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
    Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
    Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease.
    Seljeflot I; Tonstad S; Hjermann I; Arnesen H
    Atherosclerosis; 2002 May; 162(1):179-85. PubMed ID: 11947912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mud-pack treatment on plasma cytokine and soluble adhesion molecule levels in healthy volunteers.
    Basili S; Martini F; Ferroni P; Grassi M; Sili Scavalli A; Streva P; Cusumano G; Musca A; Battista Rini G
    Clin Chim Acta; 2001 Dec; 314(1-2):209-14. PubMed ID: 11718697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients.
    Chan LW; Luo XP; Ni HC; Shi HM; Liu L; Wen ZC; Gu XY; Qiao J; Li J
    Braz J Med Biol Res; 2015 Feb; 48(2):167-73. PubMed ID: 25466164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients.
    Gori AM; Cesari F; Marcucci R; Giusti B; Paniccia R; Antonucci E; Gensini GF; Abbate R
    Atherosclerosis; 2009 Jan; 202(1):255-62. PubMed ID: 18486134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
    Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
    Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation and P-selectin levels during exercise treadmill test in patients with ischaemic heart disease.
    Kobusiak-Prokopowicz M; Kuliczkowski W; Karolko B; Prajs I; Mazurek W
    Kardiol Pol; 2006 Oct; 64(10):1094-100; discussion 1101. PubMed ID: 17089241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.
    Layne K; Di Giosia P; Ferro A; Passacquale G
    Cardiovasc Res; 2016 Jul; 111(1):26-33. PubMed ID: 27118470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia.
    Ferro D; Parrotto S; Basili S; Alessandri C; Violi F
    J Am Coll Cardiol; 2000 Aug; 36(2):427-31. PubMed ID: 10933353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy.
    Cipollone F; Mezzetti A; Porreca E; Di Febbo C; Nutini M; Fazia M; Falco A; Cuccurullo F; Davì G
    Circulation; 2002 Jul; 106(4):399-402. PubMed ID: 12135935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia.
    Undas A; Celinska-Löwenhoff M; Domagala TB; Iwaniec T; Dropinski J; Löwenhoff T; Szczeklik A
    Thromb Haemost; 2005 Jul; 94(1):193-9. PubMed ID: 16113803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.